This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Memorial Sloan Kettering Cancer Center, Takeda Pharmaceutical Company Limited. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 618 
1 out of 1,226 
Years Active: 2018-2026
Title: Alexander Rudensky: Innovator in Cancer Research
Introduction
Alexander Rudensky is a prominent inventor based in New York, NY (US), known for his significant contributions to cancer research. With a total of 3 patents, he has made strides in developing methods for diagnosing and treating cancer.
Latest Patents
Rudensky's latest patents focus on depleting tumor-specific regulatory T cells (Tregs). The inventions provide methods and compositions for diagnosing and treating cancer by targeting CCR8. These technologies are particularly aimed at depleting Treg cells, especially those that infiltrate tumors.
Career Highlights
Rudensky is affiliated with the Memorial Sloan Kettering Cancer Center, where he conducts groundbreaking research in immunology and cancer treatment. His work has been instrumental in advancing the understanding of Treg cells and their role in cancer progression.
Collaborations
One of his notable collaborators is George Plitas, with whom he has worked on various projects related to cancer immunotherapy.
Conclusion
Alexander Rudensky's innovative work in cancer research continues to pave the way for new therapeutic strategies. His patents reflect a commitment to improving cancer treatment and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile